These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 4828165)

  • 41. [Therapy of hypochromic anemia using ferrous sulfate (comparative study of reinforced sustained-release pills and conventional pills)].
    Murgel GA
    Rev Bras Med; 1969 Jun; 26(6):375-9. PubMed ID: 5360578
    [No Abstract]   [Full Text] [Related]  

  • 42. [Prophylactic use of lithium carbonate in manic-depressive psychosis (results of therapy and methods of assessment)].
    Mikhalenko IN; Nuller IuL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1971; 71(5):752-7. PubMed ID: 5122141
    [No Abstract]   [Full Text] [Related]  

  • 43. Absorption and excretion of lithium in manic-depressive disease.
    Platman SR; Rorlich J; Fieve RR
    Dis Nerv Syst; 1968 Nov; 29(11):733-8. PubMed ID: 5717288
    [No Abstract]   [Full Text] [Related]  

  • 44. [Compliance with and tolerance of sustained-release lithium carbonate].
    Lavantes B; Senimon F; Bayle FJ
    Encephale; 1999; 25(2):152-7. PubMed ID: 10370888
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bioavailabiltity and side effects of different lithium carbonate products.
    Grof P; MacCrimmon D; Saxena B; Daigle L; Prio M
    Neuropsychobiology; 1976; 2(5-6):313-23. PubMed ID: 1029807
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [On the pharmacokinetics of a new application form of lithium with protracted effect (author's transl)].
    Motýlová A; Molcan J; Chalabala M
    Cesk Psychiatr; 1978 Jun; 74(3):133-8. PubMed ID: 699123
    [No Abstract]   [Full Text] [Related]  

  • 47. Pharmacodynamic and pharmacokinetic study of a slow-release formulation of furosemide in man.
    Ebihara A; Tawara K; Oka T
    Arzneimittelforschung; 1983; 33(1):163-6. PubMed ID: 6681970
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Urinary sulfates as a biologic indicator of exposure to methylsulfate compounds in manufacture of sulfate cellulose].
    Meshchakova NM; Dorogova VB; Taranenko NA; Gorbunova LA; D'iakovich MP
    Med Tr Prom Ekol; 1997; (7):24-6. PubMed ID: 9377037
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel technique for assessing the sources of dietary sodium.
    Sanchez-Castillo CP; Warrender S; Whitehead T; James WP
    Ann Clin Res; 1984; 16 Suppl 43():44-8. PubMed ID: 6442962
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A pilot trial of lithium carbonate in recurrent affective disorders.
    Melia PI
    J Ir Med Assoc; 1967 May; 60(359):160-70. PubMed ID: 6046605
    [No Abstract]   [Full Text] [Related]  

  • 51. [Clinico-experimental study on the start of the pharmacological action of an oral classical antihistaminic without and with delayed-action effect on the length of effect of the delayed-action type].
    Gottmann-Lückerath I
    Med Welt; 1983 May; 34(18):548-51. PubMed ID: 6135134
    [No Abstract]   [Full Text] [Related]  

  • 52. [Prophylactic administration of lithium carbonate in affective psychoses].
    Svestka J; Náhunek K; Rodová A
    Cesk Psychiatr; 1971 Apr; 67(2):79-86. PubMed ID: 5554019
    [No Abstract]   [Full Text] [Related]  

  • 53. Prediction of lithium carbonate dosage in psychiatric inpatients using the repeated one-point method.
    Marr MA; Djuric PE; Ritschel WA; Garver DL
    Clin Pharm; 1983; 2(3):243-8. PubMed ID: 6411413
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of the dosage schedules during the administration of retarded lithium carbonate.
    Balon R; Kabes J
    Act Nerv Super (Praha); 1981 Dec; 23(4):278-80. PubMed ID: 6801905
    [No Abstract]   [Full Text] [Related]  

  • 55. A comparison of the plasma profiles of two slow release theophylline preparations in asthmatic patients and healthy volunteers.
    Langaker KE; Bredesen JE; Holland A
    Br J Clin Pract Suppl; 1984; 35():50-2. PubMed ID: 6433960
    [No Abstract]   [Full Text] [Related]  

  • 56. [Lithium ion concentration levels of plasma and erythrocytes during treatment of psychoses with lithium carbonate].
    Bukowczyk A; Horodnicki J; Wasik A; Janicka B
    Psychiatr Pol; 1974; 8(2):137-42. PubMed ID: 4830320
    [No Abstract]   [Full Text] [Related]  

  • 57. Lithium sulphate Gastrointestinal Diffusion System: how to avoid a lag-time effect?
    Jedras Z; Janicki S
    Pharmazie; 1991 Jul; 46(7):536-7. PubMed ID: 1784616
    [No Abstract]   [Full Text] [Related]  

  • 58. [Unwanted effects of lithium therapy (preliminary results of an enquiry) (author's transl)].
    Dick P
    Ther Umsch; 1975 Aug; 32(8):532-5. PubMed ID: 1162639
    [No Abstract]   [Full Text] [Related]  

  • 59. Letter: Management of lithium treatment.
    Hullin RP; Tyrer SP
    Br Med J; 1975 Feb; 1(5952):269. PubMed ID: 1111772
    [No Abstract]   [Full Text] [Related]  

  • 60. [Excretion of orally administered d,l-1-(4-hydroxy-phenyl)-1-hydroxy-2-n-butylaminoethane-sulfate in urine in man. Experiments with a new depot form].
    Danneberg PB; Hahn R
    Arzneimittelforschung; 1969 Apr; 19(4):641-3. PubMed ID: 4389085
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.